Chester County News and Community Website
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced its financial results for the second quarter of 2024, alongside significant advancements in its oncology pipeline and recent corporate …
ArriVent BioPharma Reports Strong Second Quarter and Highlights Progress Read More NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced that it will present significant interim findings from its randomized Phase 1b FURTHER study on firmonertinib monotherapy. This presentation …
ArriVent BioPharma to Present Groundbreaking Data at 2024 World Conference on Lung Cancer Read More SUZHOU, China and NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. announced a strategic collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (“Alphamab”) to develop and commercialize novel antibody drug conjugates (ADCs) …
ArriVent BioPharma Partners with Alphamab to Develop Cutting-Edge Cancer Treatments Read More NEWTON SQUARE, PA — ArriVent BioPharma, Inc. announced the appointment of Dr. John Hohneker to its Board of Directors. With over three decades of experience in leading biopharmaceutical ventures and …
ArriVent BioPharma Bolsters Board with Biopharmaceutical Expert Dr. John Hohneker Read More NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced positive strides in its first-quarter progress, particularly in the development of firmonertinib, a promising drug for non-small cell lung …
ArriVent BioPharma Advances in Lung Cancer Research, Sets Sights on Future Milestones Read More NEWTON SQUARE, PA — ArriVent BioPharma, Inc., a burgeoning force in the quest to combat non-small cell lung cancer (NSCLC), this week announced a significant addition to its leadership team. …
ArriVent BioPharma Enhances Board with Biopharmaceutical Veteran Kristine Peterson Read More